Edward Stadtmauer, MDEnriched profile
Roseman, Tarte, Harrow, and Shaffer Families' President's Distinguished Professor; Director of Hematologic Malignancies Clinical/Translational Research, Division of Hematology-Oncology · University of Pennsylvania, Perelman School of Medicine / Abramson Cancer Center, Division of Hematology-Oncology
Overview
Updated 14 Jul 2026
Edward A. Stadtmauer, MD, is Roseman, Tarte, Harrow, and Shaffer Families' President's Distinguished Professor at University of Pennsylvania, Perelman School of Medicine / Abramson Cancer Center, Division of Hematology-Oncology. The public record shows 630 publications with 36,500 citations (h-index 88), centered on Hematology. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 10 companies, 7 NIH-funded awards (1999–2026).
- Most recent indexed publication: 2024 · bioRxiv
- Top research focus: Hematology
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 10 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 5 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Assessing the Impact of a Financial Navigation Program for Patients With Multiple Myeloma
Sponsor: Abramson Cancer Center at Penn Medicine
InvestigatorCompletedNCT05448196 - Study to Evaluate the Safety and Efficacy of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients
Sponsor: Sorrento Therapeutics, Inc.
InvestigatorPhase 1CompletedNCT03464916 - NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)
Sponsor: University of Pennsylvania
InvestigatorPhase 1TerminatedNCT03399448
Industry payments
Updated 14 Jul 2026
10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20259 payments
- GENZYME CORPORATIONProgram year20252 payments
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
NIH funding
Updated 14 Jul 2026
7 NIH research awards on record, funded 1999–2026 per NIH RePORTER. The latest:
- BMT CTN Core- University of Pennsylvania Abramson Cancer Center
University of Pennsylvania
FY2025$239,933UG1HL069286
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
Perelman Center for Advanced Medicine, 12th Floor South Pavilion, Suite 12-171, 3400 Civic Center Blvd, Philadelphia, PA 19104
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
- Residency
Albert Einstein College of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗ - Hematology-Oncology Fellowship
University of Pennsylvania Health System
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
Editorial & leadership rolesjournal and society appointments
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →79classmates.net ↗
- Co-Leader
Hematologic Malignancies Program, Abramson Cancer Center, University of Pennsylvania
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗ - Co-Leader
Hematologic Malignancies Translational Center of Excellence, Penn Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
- DuPont Guerry
IV, MD Award for Outstanding Mentorship (Penn Medicine)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →79classmates.net ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →79classmates.net ↗
Secondary affiliationsappointments beyond the home institution
- Member
Penn Center for Myeloproliferative Neoplasms
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗ - Advisor/collaborator
Parker Institute for Cancer Immunotherapy
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →parkerici.org ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →treatingbloodcancers.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by otherswhere others cite or feature them
- ResearchGate
researchgate.net/scientific-contributions/Edward-A-Stadtmauer-39464686
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗ - X / Twitter
x.com/pennmdforum/status/956882061889101824
- Facebook
m.facebook.com/TheASCOPost/videos/edward-a-stadtmauer-md-on-advanced-multiple-myeloma-and-sarcoma-first-in-human-a/290475125190178
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →m.facebook.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this specialty yet.